Bionano Genomics (BNGO) announced that Al Luderer, chairman of Bionano’s board of directors, has been appointed interim president and chief executive officer, effective May 5. Luderer will continue to serve as chairman, and director Chris Twomey will serve as lead independent director. He succeeds Erik Holmlin who is staying on as an advisor.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNGO:
- BioNano Genomics Names Interim CEO Amid Leadership Transition
- Bionano Genomics price target lowered to $6 from $7 at H.C. Wainwright
- Bionano Genomics Earnings Call: Margin Gains, Growth Test
- Closing Bell Movers: Core Labs falls after below-consensus pre-announcement
- Bionano Genomics Earnings Update: Did it Beat Estimate Forecasts?